Global (United States, European Union and China) Codeine Market Research Report 2019-2025
Table of Contents
1 Codeine Market Overview
- 1.1 Product Overview and Scope of Codeine
- 1.2 Codeine Segment by Ingredient
- 1.2.1 Global Codeine Sales Growth Rate Comparison by Ingredient (2021-2026)
- 1.2.2 Single-ingredient Codeine
- 1.2.3 Multi-ingredient Medications
- 1.3 Codeine Segment by Application
- 1.3.1 Codeine Sales Comparison by Application: 2020 VS 2026
- 1.3.2 Narcotic Analgesic
- 1.3.3 Antitussive
- 1.3.4 Others
- 1.4 Global Codeine Market Size Estimates and Forecasts
- 1.4.1 Global Codeine Revenue 2015-2026
- 1.4.2 Global Codeine Sales 2015-2026
- 1.4.3 Codeine Market Size by Region: 2020 Versus 2026
2 Global Codeine Market Competition by Manufacturers
- 2.1 Global Codeine Sales Market Share by Manufacturers (2015-2020)
- 2.2 Global Codeine Revenue Share by Manufacturers (2015-2020)
- 2.3 Global Codeine Average Price by Manufacturers (2015-2020)
- 2.4 Manufacturers Codeine Manufacturing Sites, Area Served, Product Type
- 2.5 Codeine Market Competitive Situation and Trends
- 2.5.1 Codeine Market Concentration Rate
- 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
- 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
- 2.7 Primary Interviews with Key Codeine Players (Opinion Leaders)
3 Codeine Retrospective Market Scenario by Region
- 3.1 Global Codeine Retrospective Market Scenario in Sales by Region: 2015-2020
- 3.2 Global Codeine Retrospective Market Scenario in Revenue by Region: 2015-2020
- 3.3 North America Codeine Market Facts & Figures by Country
- 3.3.1 North America Codeine Sales by Country
- 3.3.2 North America Codeine Sales by Country
- 3.3.3 U.S.
- 3.3.4 Canada
- 3.4 Europe Codeine Market Facts & Figures by Country
- 3.4.1 Europe Codeine Sales by Country
- 3.4.2 Europe Codeine Sales by Country
- 3.4.3 Germany
- 3.4.4 France
- 3.4.5 U.K.
- 3.4.6 Italy
- 3.4.7 Russia
- 3.5 Asia Pacific Codeine Market Facts & Figures by Region
- 3.5.1 Asia Pacific Codeine Sales by Region
- 3.5.2 Asia Pacific Codeine Sales by Region
- 3.5.3 China
- 3.5.4 Japan
- 3.5.5 South Korea
- 3.5.6 India
- 3.5.7 Australia
- 3.5.8 Taiwan
- 3.5.9 Indonesia
- 3.5.10 Thailand
- 3.5.11 Malaysia
- 3.5.12 Philippines
- 3.5.13 Vietnam
- 3.6 Latin America Codeine Market Facts & Figures by Country
- 3.6.1 Latin America Codeine Sales by Country
- 3.6.2 Latin America Codeine Sales by Country
- 3.6.3 Mexico
- 3.6.3 Brazil
- 3.6.3 Argentina
- 3.7 Middle East and Africa Codeine Market Facts & Figures by Country
- 3.7.1 Middle East and Africa Codeine Sales by Country
- 3.7.2 Middle East and Africa Codeine Sales by Country
- 3.7.3 Turkey
- 3.7.4 Saudi Arabia
- 3.7.5 U.A.E
4 Global Codeine Historic Market Analysis by Ingredient
- 4.1 Global Codeine Sales Market Share by Ingredient (2015-2020)
- 4.2 Global Codeine Revenue Market Share by Ingredient (2015-2020)
- 4.3 Global Codeine Price Market Share by Ingredient (2015-2020)
- 4.4 Global Codeine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Codeine Historic Market Analysis by Application
- 5.1 Global Codeine Sales Market Share by Application (2015-2020)
- 5.2 Global Codeine Revenue Market Share by Application (2015-2020)
- 5.3 Global Codeine Price by Application (2015-2020)
6 Company Profiles and Key Figures in Codeine Business
- 6.1 Taiji
- 6.1.1 Corporation Information
- 6.1.2 Taiji Description, Business Overview and Total Revenue
- 6.1.3 Taiji Codeine Sales, Revenue and Gross Margin (2015-2020)
- 6.1.4 Taiji Products Offered
- 6.1.5 Taiji Recent Development
- 6.2 Mallinckrodt
- 6.2.1 Mallinckrodt Codeine Production Sites and Area Served
- 6.2.2 Mallinckrodt Description, Business Overview and Total Revenue
- 6.2.3 Mallinckrodt Codeine Sales, Revenue and Gross Margin (2015-2020)
- 6.2.4 Mallinckrodt Products Offered
- 6.2.5 Mallinckrodt Recent Development
- 6.3 TEVA
- 6.3.1 TEVA Codeine Production Sites and Area Served
- 6.3.2 TEVA Description, Business Overview and Total Revenue
- 6.3.3 TEVA Codeine Sales, Revenue and Gross Margin (2015-2020)
- 6.3.4 TEVA Products Offered
- 6.3.5 TEVA Recent Development
- 6.4 Johnson & Johnson
- 6.4.1 Johnson & Johnson Codeine Production Sites and Area Served
- 6.4.2 Johnson & Johnson Description, Business Overview and Total Revenue
- 6.4.3 Johnson & Johnson Codeine Sales, Revenue and Gross Margin (2015-2020)
- 6.4.4 Johnson & Johnson Products Offered
- 6.4.5 Johnson & Johnson Recent Development
- 6.5 Medreich
- 6.5.1 Medreich Codeine Production Sites and Area Served
- 6.5.2 Medreich Description, Business Overview and Total Revenue
- 6.5.3 Medreich Codeine Sales, Revenue and Gross Margin (2015-2020)
- 6.5.4 Medreich Products Offered
- 6.5.5 Medreich Recent Development
- 6.6 Sanofi Aventis
- 6.6.1 Sanofi Aventis Codeine Production Sites and Area Served
- 6.6.2 Sanofi Aventis Description, Business Overview and Total Revenue
- 6.6.3 Sanofi Aventis Codeine Sales, Revenue and Gross Margin (2015-2020)
- 6.6.4 Sanofi Aventis Products Offered
- 6.6.5 Sanofi Aventis Recent Development
- 6.7 Cipla
- 6.6.1 Cipla Codeine Production Sites and Area Served
- 6.6.2 Cipla Description, Business Overview and Total Revenue
- 6.6.3 Cipla Codeine Sales, Revenue and Gross Margin (2015-2020)
- 6.4.4 Cipla Products Offered
- 6.7.5 Cipla Recent Development
- 6.8 Hikma
- 6.8.1 Hikma Codeine Production Sites and Area Served
- 6.8.2 Hikma Description, Business Overview and Total Revenue
- 6.8.3 Hikma Codeine Sales, Revenue and Gross Margin (2015-2020)
- 6.8.4 Hikma Products Offered
- 6.8.5 Hikma Recent Development
- 6.9 Pharmaceutical Associates
- 6.9.1 Pharmaceutical Associates Codeine Production Sites and Area Served
- 6.9.2 Pharmaceutical Associates Description, Business Overview and Total Revenue
- 6.9.3 Pharmaceutical Associates Codeine Sales, Revenue and Gross Margin (2015-2020)
- 6.9.4 Pharmaceutical Associates Products Offered
- 6.9.5 Pharmaceutical Associates Recent Development
- 6.10 Novartis
- 6.10.1 Novartis Codeine Production Sites and Area Served
- 6.10.2 Novartis Description, Business Overview and Total Revenue
- 6.10.3 Novartis Codeine Sales, Revenue and Gross Margin (2015-2020)
- 6.10.4 Novartis Products Offered
- 6.10.5 Novartis Recent Development
- 6.11 Apotex
- 6.11.1 Apotex Codeine Production Sites and Area Served
- 6.11.2 Apotex Codeine Description, Business Overview and Total Revenue
- 6.11.3 Apotex Codeine Sales, Revenue and Gross Margin (2015-2020)
- 6.11.4 Apotex Products Offered
- 6.11.5 Apotex Recent Development
- 6.12 Mylan
- 6.12.1 Mylan Codeine Production Sites and Area Served
- 6.12.2 Mylan Codeine Description, Business Overview and Total Revenue
- 6.12.3 Mylan Codeine Sales, Revenue and Gross Margin (2015-2020)
- 6.12.4 Mylan Products Offered
- 6.12.5 Mylan Recent Development
- 6.13 Aristo Pharma GmbH
- 6.13.1 Aristo Pharma GmbH Codeine Production Sites and Area Served
- 6.13.2 Aristo Pharma GmbH Codeine Description, Business Overview and Total Revenue
- 6.13.3 Aristo Pharma GmbH Codeine Sales, Revenue and Gross Margin (2015-2020)
- 6.13.4 Aristo Pharma GmbH Products Offered
- 6.13.5 Aristo Pharma GmbH Recent Development
- 6.14 Lannett Company
- 6.14.1 Lannett Company Codeine Production Sites and Area Served
- 6.14.2 Lannett Company Codeine Description, Business Overview and Total Revenue
- 6.14.3 Lannett Company Codeine Sales, Revenue and Gross Margin (2015-2020)
- 6.14.4 Lannett Company Products Offered
- 6.14.5 Lannett Company Recent Development
- 6.15 Laboratoire Riva
- 6.15.1 Laboratoire Riva Codeine Production Sites and Area Served
- 6.15.2 Laboratoire Riva Codeine Description, Business Overview and Total Revenue
- 6.15.3 Laboratoire Riva Codeine Sales, Revenue and Gross Margin (2015-2020)
- 6.15.4 Laboratoire Riva Products Offered
- 6.15.5 Laboratoire Riva Recent Development
7 Codeine Manufacturing Cost Analysis
- 7.1 Codeine Key Raw Materials Analysis
- 7.1.1 Key Raw Materials
- 7.1.2 Key Raw Materials Price Trend
- 7.1.3 Key Suppliers of Raw Materials
- 7.2 Proportion of Manufacturing Cost Structure
- 7.3 Manufacturing Process Analysis of Codeine
- 7.4 Codeine Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
- 8.1 Marketing Channel
- 8.2 Codeine Distributors List
- 8.3 Codeine Customers
9 Market Dynamics
- 9.1 Market Trends
- 9.2 Opportunities and Drivers
- 9.3 Challenges
- 9.4 Porter's Five Forces Analysis
10 Global Market Forecast
- 10.1 Global Codeine Market Estimates and Projections by Ingredient
- 10.1.1 Global Forecasted Sales of Codeine by Ingredient (2021-2026)
- 10.1.2 Global Forecasted Revenue of Codeine by Ingredient (2021-2026)
- 10.2 Codeine Market Estimates and Projections by Application
- 10.2.1 Global Forecasted Sales of Codeine by Application (2021-2026)
- 10.2.2 Global Forecasted Revenue of Codeine by Application (2021-2026)
- 10.3 Codeine Market Estimates and Projections by Region
- 10.3.1 Global Forecasted Sales of Codeine by Region (2021-2026)
- 10.3.2 Global Forecasted Revenue of Codeine by Region (2021-2026)
- 10.4 North America Codeine Estimates and Projections (2021-2026)
- 10.5 Europe Codeine Estimates and Projections (2021-2026)
- 10.6 Asia Pacific Codeine Estimates and Projections (2021-2026)
- 10.7 Latin America Codeine Estimates and Projections (2021-2026)
- 10.8 Middle East and Africa Codeine Estimates and Projections (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
- 12.1 Methodology/Research Approach
- 12.1.1 Research Programs/Design
- 12.1.2 Market Size Estimation
- 12.1.3 Market Breakdown and Data Triangulation
- 12.2 Data Source
- 12.2.1 Secondary Sources
- 12.2.2 Primary Sources
- 12.3 Author List
The global Codeine market is valued at US$ 313 million in 2020 is expected to reach US$ 205.7 million by the end of 2026, growing at a CAGR of -5.5% during 2021-2026.
This report focuses on Codeine volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Codeine market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China, Japan, Middle East and India etc.
Market Segment Analysis
The research report includes specific segments by Ingredient and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Ingredient, the Codeine market is segmented into
Single-ingredient Codeine
Multi-ingredient Medications
Segment by Application
Narcotic Analgesic
Antitussive
Others
Global Codeine Market: Regional Analysis
The Codeine market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Ingredient and by Application segment in terms of sales and revenue for the period 2015-2026.
The key regions covered in the Codeine market report are:
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Global Codeine Market: Competitive Analysis
This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.
The major players in global Codeine market include:
Taiji
Mallinckrodt
TEVA
Johnson & Johnson
Medreich
Sanofi Aventis
Cipla
Hikma
Pharmaceutical Associates
Novartis
Apotex
Mylan
Aristo Pharma GmbH
Lannett Company
Laboratoire Riva